Jose Manuel Otero, Chief Operating Officer at Lexeo Therapeutics, Inc. (LXEO), sold 4,666 shares at $4.48 ($21K) on 2026-07-01, disclosed to the SEC on 2026-07-01.
Open-market sale of $21k LXEO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LXEO | SELL | 2026-02-20 | $7K | — | Filing → |
| LXEO | SELL | 2026-02-20 | $19K | — | Filing → |
| LXEO | SELL | 2025-11-20 | $7K | — | Filing → |